You are here

Article Text

Article menu
Download PDFPDF
Country focus: Belgium
Notification of implants
  1. Dominique Wouters
  1. Correspondence to Dominique Wouters, Pharmacy, Cliniques Universitaires St-Luc, 10 Avenue Hippocrate, Brussels 1200, Belgium; dominique.wouters{at}uclouvain.be

https://doi.org/10.1136/ejhpharm-2012-000118

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The healthcare legislation dated 13 December 2006 made it compulsory to notify the National Institute for Health and Disability Insurance (NIHDI) of all implantable medical devices in Belgium. The new legislation aims to set identical invoicing conditions for hospitals, whether patients are cared for in Ostend, Brussels or Arlon.

    This new regulation applies to reimbursement for invasive implants and medical devices and allows for notification of implants bearing a European Commission certificate. Companies that market implants in Belgium must directly notify the NIHDI of their products. Implants that have not been notified, but …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.